Kanbi  Pharma  Teknoloji  Limite
540737-29-9 Tofacitinib Sitrat

540737-29-9 Tofacitinib Sitrat

CAS: 540737-29-9
MF: C16H20N6O.C6H8O7
MW: 504.497
Einecs: 638-826-4
MDL No.:MFCD11616529

Voye rechèch
Dekri teren

Pwopriyete
Pwen k ap fonn: 201 Degre (Decomp)
Depo tanperati. chanm tanperati
Solubility DMSO: soluble5mg/ml (solisyon klè; chofe)
Aparans blan pou poud bèlj

 

Aplikasyon:

Tofacitinib (CP -690550) Sitrat se yon inibitè roman JAK3 ak yon IC50 nan 1 nm, ak selectivite li yo nan direksyon pou JAK2 ak JAK1 se 20 a 100 fwa pi ba yo.

 

Sinonim:

Tofacitinib Sitrat

540737-29-9

Tasocitinib Sitrat

Xeljanz

Tofacitinib (CP -690550) Sitrat

Tofacitinib (Sitrat)

Tasocitinib monocitrate

Tofacitinib monocitrate

3- ((3r, 4r) -4- methyl -3- (methyl (7h-pirrolo [2, 3- d] pyrimidin -4- Yl) Amino) Piperidin -1- 2- Hydroxypropane -1, 2, 3- Tricarboxylate

1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)- beta-oxo-, (3R,4R)-, 2- Hydroxy -1, 2, 3- propanetricarboxylate (1: 1)

2- hydroxypropane -1, 2, 3- asid tricarboxylic; 3- [(3r, 4r) -4- methyl -3- [methyl ({7h-pirrolo [2, 3- d] pyr imidin -4- yl}) amino] piperidin -1- yl] -3- oxopropanenitrile

2- hydroxypropane -1, 2, 3- Tricarboxylic asid; 3- [(3r, 4r) -4- methyl -3- [methyl (7h-pirrolo [2, 3- d] pyrimidin {{13}

3- ((3r, 4r) -4- methyl -3- (methyl (7h-pirrolo (2, 3- d) Pyrimidin -4- yl) Amino) Piper Idin -1- yl) -3- oxo-propanenitrile 2- hydroxypropane -1, 2, 3- Tricarboxylate (1: 1)

3- ((3r, 4r) -4- methyl -3- (methyl (7h-pyrrolo (2, 3- d) pyrimidin -4- Yl) { 2- Hydroxypropane -1, 2, 3- Tricarboxylate

3- {(3r, 4r) -4- methyl -3- [methyl (7h-pirrolo [2, 3- d] pyrimidin {{9} 2- Hydroxypropane -1, 2, 3- Tricarboxylate

3- {(3r, 4r) -4- methyl -3- [methyl- (7h-pirrolo [2, 3- d] pyri midin -4- yl) -amino] -piperidin -1- yl} -3- oxo-propionitrile Sitrat sèl

3- {(3r, 4r) -4- methyl -3- [methyl- (7h-pirrolo [2, 3- d] pyri midin -4- yl} -amino] -piperidin -1- yl) -3- oxo-propionitrile Sitrat sèl

Xeljanz (TN)

Xeljanzxr

Tasocitinib sèl asid asid

Tofacitinib Sitrat [Jan]

C16H20N6O.C6H8O7

Syikufdoyjfgbq-ilafaasesa-n

Tofacitinib (Sitrat) (estanda)

Tofacitinib monocitrate [MI]

Tofacitinib Sitrat [WHO-DD]

AKOS022178222

Tofacitinib citrate, >=98% (HPLC)

Tofacitinib Sitrat [Orange Liv]

CP 690550 Sitrat (Tofacitinib Sitrat)

Tofacitinib Sitrat (CP -690550 Sitrat)

(3r, 4r) -4- methyl -3- (methyl -7 h-pyrro lo [2, 3- d] pyrimidin -4- ylamino) -beta-oxo -1- PiperIDEREDIN

(3r, 4r) -4- methyl -3- (methyl -7 h-pyrolo [2, 3- d] pyrimidin -4- ylamino) -beta-oxo -1- Piperidin Piperine}}}}}}}}}} {{ 2- Hydroxy -1, 2, 3- propanetricarboxylate

1- piperidinepropanenitrile, 4- methyl -3- (methyl -7 H-pyrolo (2, 3- d) Pyrimidin -4- ylamino)-. 2- Hydroxy -1, 2, 3- propanetricarboxylate

 

Baj popilè: 540737-29-9 Tofacitinib Sitrat, Lachin 540737-29-9 Tofacitinib Sitrat Konpayi fabrikasyon, Swèd

Inquiry
goTop

(0/10)

clearall